Notice of Intent to Publish a Request for Applications for Clinical Research Centers to establish the Network for Excellence in Neuroscience Clinical Trials (NEXT Sites - U10)


Notice Number: NOT-NS-10-025

Key Dates

Release Date: September 7, 2010

Related Notices

NOT-NS-10-026 and NOT-NS-10-027

Issued by

National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

The National Institute of Neurological Disorders and Stroke (NINDS) intends to issue a Request for Applications (RFA) for U10 grant applications in support of clinical research sites to establish the Network for Excellence in Neuroscience Clinical Trials (NEXT). This clinical research network will develop and conduct multiple early stage clinical trials and research studies to enable the efficient testing of the most promising therapies from academia or industry. Examples include proof-of concept trials and preparatory studies aimed at validating biomarkers and clinical outcomes in neurological disorders including pediatric patients and rare diseases. The network will provide a robust, standardized, and accessible infrastructure to rapidly develop protocols and will coordinate a cadre of specialist investigators to implement studies efficiently.

This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. Two companion RFAs will be concomitantly released, requesting U01 grant applications in support of a data coordinating center (DCC) [NOT-NS-10-027] and U01 grant applications in support of a clinical coordinating center (CCC) [NOT-NS-10-026]. Note that the currently planned RFAs will establish the collaborating Coordinating Centers and Clinical Research Sites. Separate FOAs may be published in the future to invite applications for Phase II clinical trials and preparatory research studies that will be conducted within the network.

The RFA is expected to be published in fall of 2010 with an expected receipt date in winter of 2011.

The Clinical Research Sites RFA will utilize the U10 mechanism. Details of the planned Funding Opportunity Announcement (FOA) are provided below.

Research Initiative Details

This Notice encourages investigators with expertise in clinical trials to consider applying for this new RFA.

Successful applicants for the Clinical Sites RFA (U10) will have a track record as collaborative and experienced neuroscience clinical trialists as well as institutional support.

APPLICATIONS ARE NOT BEING SOLICITED AT THIS TIME.

Inquiries

Please direct all inquiries to:

Petra Kaufmann, MD
National Institute of Neurological Disorders and Stroke
National Institutes of Health
6001 Executive Blvd., Room 2116
Bethesda, MD 20892-9520
Express/Courier: Rockville, MD 20852
Telephone: (301) 496-9135
Fax: (301) 401-5301
Email: Petra.Kaufman@nih.gov
http://www.ninds.nih.gov/